Madoka Kuramitsu

976 total citations
44 papers, 462 citations indexed

About

Madoka Kuramitsu is a scholar working on Immunology, Molecular Biology and Agronomy and Crop Science. According to data from OpenAlex, Madoka Kuramitsu has authored 44 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 16 papers in Molecular Biology and 11 papers in Agronomy and Crop Science. Recurrent topics in Madoka Kuramitsu's work include T-cell and Retrovirus Studies (14 papers), Animal Disease Management and Epidemiology (11 papers) and Vector-Borne Animal Diseases (10 papers). Madoka Kuramitsu is often cited by papers focused on T-cell and Retrovirus Studies (14 papers), Animal Disease Management and Epidemiology (11 papers) and Vector-Borne Animal Diseases (10 papers). Madoka Kuramitsu collaborates with scholars based in Japan, United States and United Kingdom. Madoka Kuramitsu's co-authors include Isao Hamaguchi, Takuo Mizukami, Haruka Momose, Kazuya Takizawa, Kazunari Yamaguchi, Atsuko Masumi, Chieko Hashizume, Masakazu Kamata, Yoko Aida and Seishiro Naito and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Madoka Kuramitsu

42 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madoka Kuramitsu Japan 14 237 192 126 84 81 44 462
Takaharu Ueno Japan 12 221 0.9× 128 0.7× 115 0.9× 117 1.4× 123 1.5× 27 458
Juan Pablo Jaworski Argentina 12 264 1.1× 120 0.6× 69 0.5× 112 1.3× 158 2.0× 22 503
Jean‐Stéphane Gatot Belgium 12 467 2.0× 272 1.4× 75 0.6× 132 1.6× 165 2.0× 16 706
Patricia Benz United States 9 292 1.2× 161 0.8× 95 0.8× 75 0.9× 116 1.4× 19 561
Kazu Okuma Japan 12 325 1.4× 86 0.4× 205 1.6× 170 2.0× 175 2.2× 42 612
Amane Sasada Japan 7 284 1.2× 99 0.5× 89 0.7× 149 1.8× 154 1.9× 12 429
Richard Hampton United States 6 178 0.8× 264 1.4× 48 0.4× 43 0.5× 45 0.6× 7 500
Cecilia Tami United States 12 191 0.8× 222 1.2× 74 0.6× 144 1.7× 270 3.3× 15 675
Hélène Valentin France 11 364 1.5× 94 0.5× 284 2.3× 42 0.5× 42 0.5× 18 580
Andrea D. Lipińska Poland 14 204 0.9× 232 1.2× 299 2.4× 30 0.4× 37 0.5× 32 611

Countries citing papers authored by Madoka Kuramitsu

Since Specialization
Citations

This map shows the geographic impact of Madoka Kuramitsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madoka Kuramitsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madoka Kuramitsu more than expected).

Fields of papers citing papers by Madoka Kuramitsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madoka Kuramitsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madoka Kuramitsu. The network helps show where Madoka Kuramitsu may publish in the future.

Co-authorship network of co-authors of Madoka Kuramitsu

This figure shows the co-authorship network connecting the top 25 collaborators of Madoka Kuramitsu. A scholar is included among the top collaborators of Madoka Kuramitsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madoka Kuramitsu. Madoka Kuramitsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murata, Megumi, Hirotaka Ode, Yasumasa Iwatani, et al.. (2025). Identification of Occult Simian T-Cell Leukemia Virus Type 1 Infection in Japanese Macaques. The Journal of Infectious Diseases. 232(2). 510–518. 1 indexed citations
2.
Tezuka, Kenta, et al.. (2024). Establishment of a novel human T-cell leukemia virus type 1 infection model using cell-free virus. Journal of Virology. 98(2). e0186223–e0186223.
3.
Momose, Haruka, Asako Murayama, N. Yamada, et al.. (2023). Performance evaluation of in vitro diagnostic kits for hepatitis B virus infection using the regional reference panel of Japan. Virology Journal. 20(1). 93–93. 6 indexed citations
4.
Hasegawa, Atsuhiko, Megumi Murata, Yoshiko Nagano, et al.. (2023). Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL responses. PLoS Pathogens. 19(2). e1011104–e1011104. 3 indexed citations
5.
Nomoto, Hidetoshi, Satoshi Kutsuna, Kazu Okuma, et al.. (2021). No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity. Journal of Infection and Chemotherapy. 27(4). 653–655. 2 indexed citations
6.
Kuramitsu, Madoka, et al.. (2020). First case of molecularly identified and genetically characterized human T-cell leukemia virus type 2 infection in a pregnant woman in non-endemic Japan. Journal of Virological Methods. 287. 114005–114005. 1 indexed citations
7.
Tezuka, Kenta, Kazu Okuma, Shoko Miura, et al.. (2020). HTLV-1 targets human placental trophoblasts in seropositive pregnant women. Journal of Clinical Investigation. 130(11). 6171–6186. 18 indexed citations
8.
Murata, Megumi, Jun‐ichirou Yasunaga, Madoka Kuramitsu, et al.. (2020). Frequent horizontal and mother-to-child transmission may contribute to high prevalence of STLV-1 infection in Japanese macaques. Retrovirology. 17(1). 15–15. 9 indexed citations
9.
10.
11.
Sasaki, Eita, Madoka Kuramitsu, Haruka Momose, et al.. (2017). A novel vaccinological evaluation of intranasal vaccine and adjuvant safety for preclinical tests. Vaccine. 35(5). 821–830. 16 indexed citations
12.
Masumi, Atsuko, Kazuya Takizawa, Takuo Mizukami, et al.. (2016). Mycobacterium avium infection induces the resistance of the interferon-γ response in mouse spleen cells at late stages of infection. Inflammation and Regeneration. 36(1). 21–21. 1 indexed citations
13.
Mizukami, Takuo, Haruka Momose, Madoka Kuramitsu, et al.. (2014). System Vaccinology for the Evaluation of Influenza Vaccine Safety by Multiplex Gene Detection of Novel Biomarkers in a Preclinical Study and Batch Release Test. PLoS ONE. 9(7). e101835–e101835. 24 indexed citations
14.
Masumi, Atsuko, Masahiko Ito, Isao Hamaguchi, et al.. (2009). Enhanced RIG-I expression is mediated by interferon regulatory factor-2 in peripheral blood B cells from hepatitis C virus-infected patients. Biochemical and Biophysical Research Communications. 391(4). 1623–1628. 11 indexed citations
15.
Masumi, Atsuko, Isao Hamaguchi, Madoka Kuramitsu, et al.. (2009). Interferon regulatory factor‐2 induces megakaryopoiesis in mouse bone marrow hematopoietic cells. FEBS Letters. 583(21). 3493–3500. 15 indexed citations
16.
Mizukami, Takuo, Madoka Kuramitsu, Kazuya Takizawa, et al.. (2008). Identification of Transcripts Commonly Expressed in Both Hematopoietic and Germ-Line Stem Cells. Stem Cells and Development. 17(1). 67–80. 13 indexed citations
17.
Hamaguchi, Isao, Jun‐ichi Imai, Haruka Momose, et al.. (2008). Application of quantitative gene expression analysis for pertussis vaccine safety control. Vaccine. 26(36). 4686–4696. 14 indexed citations
18.
Kuramitsu, Madoka, Isao Hamaguchi, Takuo Mizukami, et al.. (2008). Deficient RPS19 protein production induces cell cycle arrest in erythroid progenitor cells. British Journal of Haematology. 140(3). 348–359. 21 indexed citations
19.
Hashizume, Chieko, et al.. (2007). Human immunodeficiency virus type 1 Vpr interacts with spliceosomal protein SAP145 to mediate cellular pre-mRNA splicing inhibition. Microbes and Infection. 9(4). 490–497. 40 indexed citations
20.
Ogura, Hironao, Mikiya Fujieda, Kazuhiko Matsumoto, et al.. (1985). [Clinical efficacy of aztreonam in refractory infections in children].. PubMed. 38(11). 3349–57. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takaharu Ueno Breakdown of academic impact, for papers by Juan Pablo Jaworski Breakdown of academic impact, for papers by Jean‐Stéphane Gatot Breakdown of academic impact, for papers by Patricia Benz Breakdown of academic impact, for papers by Kazu Okuma Breakdown of academic impact, for papers by Amane Sasada Breakdown of academic impact, for papers by Richard Hampton Breakdown of academic impact, for papers by Cecilia Tami Breakdown of academic impact, for papers by Hélène Valentin Breakdown of academic impact, for papers by Andrea D. Lipińska
Rankless by CCL
2026